parthenolide and Eye Cancer, Retinoblastoma

parthenolide has been researched along with Eye Cancer, Retinoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augello, G; Carlisi, D; D'Anneo, A; De Blasio, A; Di Fiore, R; Drago-Ferrante, R; Giuliano, M; Tesoriere, G; Vento, R	1

Other Studies

1 other study(ies) available for parthenolide and Eye Cancer, Retinoblastoma

Article	Year
In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player. Cancer biology & therapy, 2013, Oct-01, Volume: 14, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Shape; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression; Glutathione; Humans; Okadaic Acid; Oxidative Stress; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Reactive Oxygen Species; Retinoblastoma; Sesquiterpenes; Tumor Suppressor Protein p53	2013

Article

Year

In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.

Cancer biology & therapy, 2013, Oct-01, Volume: 14, Issue:10

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Shape; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression; Glutathione; Humans; Okadaic Acid; Oxidative Stress; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Reactive Oxygen Species; Retinoblastoma; Sesquiterpenes; Tumor Suppressor Protein p53

2013